Navigation auf uzh.ch

Suche

Innovation Hub

News previous years

News list

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Enzian Pharmaceutics and UZH develop a novel gastroretentive fibrous dosage form

    In a collaborative project funded by Innosuisse and Enzian Pharmaceutics, scientists at Enzian Pharmaceutics and the University of Zurich (UZH) have reached an important milestone in the development of a new gastroretentive dosage form.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Arcton raises 350k CHF in the pre-seed round

    Arcton, a UZH startup and Zurich-based fintech startup founded in 2022, disrupts the Swiss crowdfunding scene with its innovative investing platform. Crowd investing in Switzerland has experienced a significant surge in popularity, with platforms primarily focused on capital raising.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    UZH Spin-offs Successful at TOP 100 Swiss Startup Award

    On 6 September, the talent of the Swiss innovation ecosystem was showcased at the TOP 100 Swiss Startup Award 2023, organised by Venturelab.

    Within both the Top 100 Swiss Startup Ranking and the TOP 100 Swiss Scale-up Ranking, multiple UZH spin-offs were named.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    metaLead wins final stage of Venture Kick

    Venture Kick awarded CHF 150’000 to metaLead, a BioTech UZH Spinoff project, which is developing next-gen antidotes against toxic metals. 

  • UZH Biomedicine Professor Magdalini Polymenidou becomes Global Scholar

    The Novartis Institutes for BioMedical Research (NIBR) is seeking to advance science through the NIBR Global Scholars Program (NGSP). This competitive program supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Magdalini Polymenidou has been selected for the NGSP 2022 and will receive up to 1 mil USD funding over three years along with scientific expertise from NIBR collaborators.

  • eracal news

    EraCal Therapeutics collaborates with Nestlé Health Science

    Research collaboration between EraCal Therapeutics and Nestlé Health Science

  • News

    Prometheus AG wins Orbital Reef Starter Innovation Challenge

    Prometheus AG wins the Orbital Reef Starter Innovation Challenge.

  • aiEndoscopic at SIC

    aiEndoscopic wins Swiss Innovation Challenge

    Former  UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won  the Swiss Innovation Challenge 2022.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Clemedi releases Tuberculini

    Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.

  • Ana Montalban

    UZH spin-off Recolony idolized in 20 minutes

    Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.

  • Cofounder Francesco Baviano

    Arcton pitch at Start-up Nights

    UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.  

  • Deana Mohr

    MUVON Therapeutics: Phase II clinical trial started

    Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr  and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.

  • Navignostics

    Navignostics raises CHF 7.5M in seed financing round

    The UZH spin-off Navignostics raises CHF 7.5M in a seed financing round to advance precision cancer medicine through spatial single-cell proteomics.

  • Beschreibender Text (wird veröffentlicht wenn Bild nicht geladen werden kann)

    Synthara wins ZKB Pionierpreis Technopark 2023

    UZH Spin-off Synthara, a chip design startup founded by Manu V Nair and Alessandro Aimar, has been awarded the 2023 ZKB Technopark Pionierpreis. The Zurich-based company is recognised for its innovative approach to chip design, which enhances computing power and energy efficiency. 

  • Molecular Partners teams with Novartis

    Biotech spin-offs University of Zurich

    The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences.